Literature DB >> 26118190

Validity of Tissue Microarray by Immunohistochemistry.

Hiromi Fujita, Tatsuya Takayama, Naohisa Takaoka, Cheng Tan, Hisaki Igarashi, Haruhiko Sugimura, Seiichiro Ozono.   

Abstract

BACKGROUND: Tissue microarrays (TMAs) extract designated areas of tissue paraffin blocks in several units that are millimeters in diameter in a cylindrical fashion, array dozens of these tissue specimens, and then re-embed them. Here, a TMA was utilized to analyze renal cell carcinoma (RCC) specimens with anti-FABP7 and anti-Brn2 antibodies.
METHODS: Paraffin-embedded specimens from 114 RCC patients were immunostained with anti-FABP7 and anti-Brn2 antibodies to examine the rate of agreement between the staining of TMA grafts compared to conventional tissue slice grafts. The staining area of the tumor was also examined.
RESULTS: The positive ratio of anti-FABP7 was 74% and of anti-Brn2 was 57%. The rate of agreement of each antibody was 100% regardless of tumor size before extraction.
CONCLUSIONS: Immunostaining of TMA slices might be effective for the analysis of RCC specimens.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26118190     DOI: 10.7754/clin.lab.2014.141102

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  1 in total

1.  Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer.

Authors:  Yusuke Inoue; Katsuhiro Yoshimura; Kazutaka Mori; Nobuya Kurabe; Tomoaki Kahyo; Hiroki Mori; Akikazu Kawase; Masayuki Tanahashi; Hiroshi Ogawa; Naoki Inui; Kazuhito Funai; Kazuya Shinmura; Hiroshi Niwa; Takafumi Suda; Haruhiko Sugimura
Journal:  Oncotarget       Date:  2016-05-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.